Trials / Unknown
UnknownNCT03171974
Ultrasound Guided Treatment of Steroids for Capsular Contracture in Patients With Reconstructed/Augmented Breast
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Ultrasound guided treatment of steroids for capsular contracture in patients with reconstructed/augmented breast
Detailed description
The aim of this study is to evaluate ultrasound (US)-guided treatment of capsular contracture (CC) in patients with reconstructed/ augmented breast. Capsular contraction is the one of the most common complications of both esthetic and reconstructive breast surgery with an incidence of 0.5-30% and 1-38%, respectively. In irradiated patients the incidence is higher, in the range of 30-67%. It appears most commonly in the first year but in some patients, belated capsular contracture has been noticed. The more severe forms of contraction, Baker grades 3 and 4 with a firm often deformed and painful breast, have been shown to recur as often as 67% after capsulotomy steroid injection has been demonstrated to be effective for the treatment of this condition. 20-30 female with grade III\\IV CC will be included. Patients will be treated with peri-implant US-guided injection of Dexamethasone The purpose of our study is to use a longer acting steroid (Dexamethasone) injected intra capsular with US-guide. By that getting a better effect on the level of fibrosis. This Clinical study will be conducted in the tertiary academic Rabin Medical Center. Several measures will be taken, including: capsular contracture grading by two plastic surgeons, a VAS-score of breast pain, maximal capsular thickness (MCT) in sonography
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone | dexamethasone will be injected intracapsular under US |
| DEVICE | US | dexamethasone will be injected intracapsular under US |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2019-08-01
- Completion
- 2019-12-01
- First posted
- 2017-05-31
- Last updated
- 2017-10-03
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03171974. Inclusion in this directory is not an endorsement.